Minerva Neurosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Minerva Neurosciences announces its 2026 Annual Meeting of Stockholders, scheduled for June 3, 2026, to be held virtually, with key proposals including director elections and charter amendments.
NASDAQ
Minerva Neurosciences will hold its 2025 Annual Meeting to vote on increasing authorized shares, approving Series A Preferred Stock conversion, and amending its equity incentive plan, crucial for future funding and talent retention.
NASDAQ
Minerva Neurosciences, Inc. announces its 2024 Annual Meeting of Stockholders to be held on December 5, 2024, with voting open until December 4, 2024.
NASDAQ
DEF 14A: Minerva Neurosciences Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
Minerva Neurosciences will hold its annual stockholders meeting virtually on December 5, 2024, to vote on director elections, executive compensation, and auditor ratification.